Clinical Trial Detail

NCT ID NCT02886585
Title Pembrolizumab In Central Nervous System Metastases
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Massachusetts General Hospital
Indications

Advanced Solid Tumor

Therapies

Pembrolizumab

Age Groups: senior adult

No variant requirements are available.